Introduction Lung cancer is the leading cause of cancer deaths worldwide for both men and women [1]. It is the number three cancer among Indian men [2]. Chemotherapy for non–small cell lung carcinoma (NSCLC), which accounts for approximately 85% of lung cancer cases, remains marginally effective [3]. Genomic research has unveiled
No takes yet. Share an insight, caveat, or question.
Pungliya et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: